share_log

中国银河4月22日发布研报称，维持卫宁健康（300253.SZ）推荐评级。评级理由主要包括：1）医疗卫生信息化业务稳步增长，创新业务板块亏损缩窄；2）毛利率上升，控费效果显著，人均创利达新高；3）“1+X”战略持续升级，WiNEX产品助力医院数字化改革高质量发展。（每日经济新闻）

China Galaxy released a research report on April 22 stating that it maintains the Weining Health (300253.SZ) recommendation rating. The main reasons for the rating include: 1) the medical and health information technology business is growing steadily, and

Zhitong Finance ·  Apr 22 10:32
China Galaxy released a research report on April 22 stating that it maintains the Weining Health (300253.SZ) recommendation rating. The main reasons for the rating include: 1) the medical and health information technology business is growing steadily, and losses in the innovative business sector have narrowed; 2) gross margin has increased, and the cost control effect has reached a new high level of profit per capita; 3) the “1+X” strategy continues to be upgraded, and WineX products help the hospital's digital transformation and high-quality development. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment